Low prevalence of serrated polyposis syndrome in screening populations: a systematic review

Background and study aims: The most frequently cited prevalence for serrated polyposis syndrome (SPS) is 1 in every 3000 people screened, but this value is debated. Additionally, changes in 2010 in the World Health Organization (WHO) diagnostic criteria for SPS might affect reported prevalence. An updated estimate of SPS prevalence is necessary to predict the number of cases in screening programs.

Patients and methods: A systematic literature search was conducted in the PubMed, EMBASE, and Web of Science databases up to February 2014. Studies reporting the prevalence of SPS, as defined by WHO criteria, in screening populations were selected.

Results: Six studies reported prevalence of SPS in screening populations, varying from 0 to 0.66 %. The highest prevalences (0.34 % and 0.66 %) were seen in studies from screening programs with patients pre-selected by fecal blood test. Primary colonoscopy-based screening programs, that have the lowest risk of bias, reported SPS prevalences ranging from 0 to 0.09 %. Across studies, 56 patients were diagnosed with SPS of whom 3 presented with synchronous colorectal cancer at index endoscopy.

Conclusion: The true prevalence of SPS is unclear because of the risk of bias across studies, but is likely to be below 0.09 % as derived from primary colonoscopy screening programs. The prevalence in pre-selected screening populations after positive fecal testing is higher, with reported values of 0.34 % and 0.66 %. Large and high quality primary colonoscopy screening studies, reporting SPS prevalence in adequately described populations, are necessary for better estimation of the true prevalence of SPS in average-risk patients.

• References

• 1 Boparai KS, Mathus-Vliegen EM, Koornstra JJ et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010; 59: 1094-1100
• 2 Boparai KS, Reitsma JB, Lemmens V et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010; 59: 1222-1225
• 3 Snover DC, Ahnen DJ, Burt RW, Odze RD. Serrated polyps of the colon and rectum and serrated polyposis. 4th edn. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010
• 4 Burt R, Jass JR. Hyperplastic polyposis. In: Hamilton SR, Aaltonen LA, eds Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000: 135-136
• 5 Crowder CD, Sweet K, Lehman A et al. Serrated polyposis is an underdiagnosed and unclear syndrome: the surgical pathologist has a role in improving detection. Am J Surg Pathol 2012; 36: 1178-1185
• 6 Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc 2012; 75: 1206-1210
• 7 Buchanan DD, Sweet K, Drini M et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PloS One 2010; 5: e11636
• 8 Lockett MJ, Atkin WS. Hyperplastic polyposis (HPP): Prevalence and cancer risk. Gastroenterology 2001; 120: A742-A742
• 9 Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
• 10 Loney PL, Chambers LW, Bennett KJ et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998; 19: 170-176
• 11 Kahi CJ, Li XC, Eckert GJ et al. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc 2012; 75: 515-520
• 12 Hazewinkel Y, de Wijkerslooth TR, Stoop EM et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy 2014; 46: 219-224
• 13 Orlowska J, Kiedrowski M, Kaminski FM et al. Hyperplastic polyposis syndrome in asymptomatic patients: the results from the colorectal-cancer screening program. Virchows Archiv 2009; 455: 47-47
• 14 Biswas S, Ellis AJ, Guy R et al. High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS bowel cancer screening programme. Gut 2013; 62: 475
• 15 Moreira L, Pellise M, Carballal S et al. High prevalence of serrated polyposis syndrome in FIT-based colorectal cancer screening programmes. Gut 2013; 62: 476-477
• 16 West NJ, Poullis AP, Leicester RJ. The NHS Bowel Cancer Screening Programme – a realistic approach with additional benefits. Colorectal Dis 2008; 10: 708-714
• 17 Atkin WS, Cook CF, Cuzick J et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-1300
• 18 Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. NEJM 2006; 355: 1863-1872
• 19 Sterne JA, Sutton AJ, Ioannidis JP et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002
• 20 Payne SR, Church TR, Wandell M et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clinical Gastroenterol Hepatol 2014; 12: 1119-1126
• 21 Heigh RI, Yab TC, Taylor WR et al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PloS One 2014; 9: e85659
• 22 Jasperson KW, Kanth P, Kirchhoff AC et al. Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum 2013; 56: 1211-1216
• 23 Rosty C, Buchanan DD, Walsh MD et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012; 36: 876-882
• 24 Sanduleanu S, Rondagh EJ, Masclee AA. Development of expertise in the detection and classification of non-polypoid colorectal neoplasia: Experience-based data at an academic GI unit. Gastrointest Endosc Clin North Am 2010; 20: 449-460
• 25 le Clercq CM, Bouwens MW, Rondagh EJ et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 2014; 63: 957-963
• 26 van Herwaarden YJ, Bisseling TM, Nagtegaal ID. Is one colonoscopy sufficient to diagnose serrated polyposis syndrome?. Clinical Gastroenterol Hepatol 2014; 12: 1202-1203